Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist designed to help manage blood sugar levels and promote weight loss in individuals with type 2 diabetes and obesity, according to the NLM
Incorporating daily movement, such as taking the stairs or walking during breaks, can also contribute to calorie expenditure
however, this population was not evaluated in terms of detailed body composition, which is particularly relevant in older adults
Your own results will depend on your starting weight, lifestyle choices, and unique physiology
Overall Impact on the Food and Beverage Industry The reduced consumption of certain products, such as calorie-dense, high sugar products, snacks, sugary drinks, and alcohol, has been correlated with GLP1-s